Objective
to investigate the 5-year clinical outcomes of hybrid coronary revascularization (HCR) as compared to conventional CABG
Study
single-centre randomised trial
Population
patients with M-VD involving LAD and at least 1 other critical (>70%) lesion
Endpoints
all cause mortality at 5 years
Conclusion
HCR has similar 5-year mortality when compared to conventional CABG
Tajstra et al. JACC Cardiovascular Interventions. 2018;11:847-52
